253P Risk factor (RF) identification (ID) and hyperglycemia (HG) prevention with alpelisib (ALP) + fulvestrant (FLV) in PIK3CA-mutated, hormone-receptor positive (HR+), human epidermal growth factor-2 negative (HER2-) advanced breast cancer (ABC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Burnette, S; Poehlein, E; Lee, H-J; Force, J; Westbrook, K; Moore, H

Published Date

  • September 2021

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S470 - S470

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2021.08.536